Thr284

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Thr284 - eIF2-alpha (human)

Site Information
VVtDtDEtELARQME SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 5835101

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Relevant cell line - cell type - tissue:	K562 (erythroid) ( 1 )

References
1	Possemato A (2007) CST Curation Set: 2673; Year: 2007; Biosample/Treatment: cell line, K562/untreated; Disease: chronic myelogenous leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (K/R)XXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser/Thr) Akt Substrate Antibody Cat#: 9611 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.